May 14, 2013 (Fast Lane via COMTEX) -- Below are the three companies in the Drug Retail industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power. Rite Aid (NYSE:RAD) is highest with EBITDA growth of 48.4%. Rite Aid Corporation operates a retail drugstore chain in various states and the District of Columbia. The Company's stores sell prescription drugs, as well as other products such as nonprescription medications, health and beauty aids, and cosmetics. Thus far today, Rite Aid has traded 7.7 million shares, vs. average volume of 25.1 million shares per day. The stock has underperformed the Dow (-1.8% to the Dow's 0.5%) and underperformed the S&P 500 (-1.8% to the S&P's 0.7%) during today's trading.

Walgreen (NYSE:WAG) is next with EBITDA growth of 35.2%. Finishing up the top three is CVS Caremark (NYSE:CVS), with EBITDA growth of 15.1%. ---------------------------------------------------------------------------------------------

Financial News Network Online (FNNO) is a leading provider of digital financial news content for distribution on the web. You can count on FNNO to bring you the latest market news, earnings reports, analyst comments, economic data reports and more. Visit http://www.fnno.com today.

Copyright, Comtex News Network, Inc. 2013